1Grimes PE, Morris R, Avaniss-Aghajani E, et al. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines[J]. J Am Acad Dermatol, 2004, 51(1): 52-61.
4Katoh N, Hirano S, Yasuno H, et al. Effects of tacrolimus ointment on facial eruption, itch, and scratching in patients with atopic dermatitis[J]. J Dermatol. 2004, 31(3): 194-199.
3Simon D,Vassina E,Braathen LR,et al.Immunopharmacological effects of topical tacrolimus in atopic dermatitis[J].J Allergy Clin Immunol,2004,113(2):S334.
4Beck LA.The efficacy and safety of tacrolimus ointment:a clinical review[J].J Am Acad Dermatol,2005,53 (2 Suppl 2):S165-S170.
5Freeman AK,Serle J,VanVeldhuisen P,et al.Tacrolimus ointment in the treatment of eyelid dermatitis[J].Cutis,2004,73(4):267-271.
6Hengge UR,Ruzicka T,Schwartz RA,et al.Adverse effects of topical glucocorticosteroids[J].J Am Acad Dermatol,2006,54(1):1-15.
7Kyllonen H,Remitz A,Mandelin JM,et al.Effects of 1-year intermittent treatment with topical tacrolimus monotherapy on skin collagen synthesis in patients with atopic dermatitis[J].Br J Dermatol,2004,150(6):1174-1181.
8Fleischer AB Jr, Rapp SR, Reboussin DM, et al. Patient measurement of psoriasis disease severity with a structured instrument. J Invest Dermatol, 1994, 102(6): 967-969.
9Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis[J]. Acta Derm Venereol (Stockh), 1980, (Suppl 92): 44.
10Boguniewicz M, Fiedler VC, Raimer S, et al. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group [J]. J Allergy Clin Immunol, 1998, 102(4 Pt 1): 637-644.
